Ce Cao

Ce Cao

Auto-generated profile, based on publicly available information

Ce Cao

National Clinical Research Center for Chinese Medicine Cardiology Beijing Key Laboratory of Chinese Materia Pharmacology Xiyuan Hospital of China Academy of Chinese Medical Sciences Beijing China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2023 in Phytomedicine
Verified
Journal Article
Open access
LLLingmei Li
Lingmei Li
LLLei Li
Lei Li
CCCe Cao
Ce Cao
FGFan Guo
Fan Guo
AWAoao Wang
Aoao Wang
JFJianhua Fu
Jianhua Fu

3 May 2026 in Medcomm
Verified
Journal Article
Open access
PDF file
CCCe Cao
Ce Cao
BMBo Ma
Bo Ma
JZJian Zhang
Jian Zhang
LYLili Yang
Lili Yang
ZLZixin Liu
Zixin Liu
JLJianxun Liu
Jianxun Liu
Heart failure (HF) following myocardial infarction remains a leading cause of global morbidity and mortality, necessitating novel therapeutic strategies. Salvianolic acid B (SalB), one of the major active components of Salvia miltiorrhiza Bunge, has been shown to effectively reverse ischemia‐induced myocardial infarction and improve cardiac function. Here, we report a novel mechanism by which SalB treats postmyocardial infarction heart failure by promoting cardiomyocyte re‐entry into the cell cycle. A novel protein target of SalB, Prohibitin 1 (PHB1), was identified using chemical biology techniques. Experiments involving overexpression and knockdown of PHB1 have demonstrated that SalB promotes cardiomyocyte mitosis by acting on PHB1, which in turn upregulates the phosphorylation level of the Raf‐ERK pathway. Molecular dynamics simulations provide a comprehensive explanation for the mechanism by which SalB enhances Raf phosphorylation. The findings reveal that SalB binds to the C‐terminal of PHB1/2 heterodimer, inducing a conformational change that enhances Raf‐ERK pathway activation via Akt‐mediated phosphorylation, thereby promoting cardiomyocyte mitosis. The findings of this study propose a promising new molecular mechanism through which SalB can contribute to the preservation and restoration of cardiac function.